Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

McQuade

Showing results (751-760 of 1,025) with videos related to

Pageof 103
Sort By:
EJNMMI Research|July 3, 2026
[<sup>18</sup>F]MNI-1054, a novel PET ligand for lysine-specific histone demethylase 1 A (LSD1): first-in human validation and enzyme occupancy of the LSD1 inhibitor TAK-418Adam J Schwarz, Christine M Sandiego, Cristian Constantinescu, et al.
Animal Nutrition (Zhongguo Xu Mu Shou Yi Xue Hui)|October 27, 2021
Implications of excreta uric acid concentrations in broilers offered reduced-crude protein diets and dietary glycine requirements for uric acid synthesisPeter H Selle, David I Cantor, Leon R McQuade, et al.
Journal of Neurodevelopmental Disorders|August 10, 2019
Phenotypic characterization of individuals with SYNGAP1 pathogenic variants reveals a potential correlation between posterior dominant rhythm and developmental progressionAndres Jimenez-Gomez, Sizhe Niu, Fabiola Andujar-Perez, et al.
Neuropsychiatric Disease and Treatment|June 10, 2011
Long-term safety and tolerability of open-label aripiprazole augmentation of antidepressant therapy in major depressive disorderRobert M Berman, Michael E Thase, Madhukar H Trivedi, et al.
The International Journal of Neuropsychopharmacology|February 17, 2017
Aripiprazole Once-Monthly 400 mg: Comparison of Pharmacokinetics, Tolerability, and Safety of Deltoid Versus Gluteal AdministrationArash Raoufinia, Timothy Peters-Strickland, Anna-Greta Nylander, et al.
American Journal of Biological Anthropology|March 20, 2025
The Future of Forensic Anthropology Practice and Education: Competencies, Certification, and LicensureNatalie R Langley, MariaTeresa A Tersigni-Tarrant, Nicholas V Passalacqua, et al.
Plos Pathogens|February 15, 2013
Plasmodium falciparum malaria elicits inflammatory responses that dysregulate placental amino acid transportPhilippe Boeuf, Elizabeth H Aitken, Upeksha Chandrasiri, et al.
Journal of Psychopharmacology (Oxford, England)|December 17, 2009
Evaluation of akathisia in patients with schizophrenia, schizoaffective disorder, or bipolar I disorder: a post hoc analysis of pooled data from short- and long-term aripiprazole trialsJohn M Kane, Thomas R E Barnes, Christoph U Correll, et al.
Journal of Clinical Psychopharmacology|April 7, 2017
Aripiprazole Once-Monthly in the Treatment of Acute Psychotic Episodes in Schizophrenia: Post Hoc Analysis of Positive and Negative Syndrome Scale Marder Factor ScoresZahinoor Ismail, Timothy Peters-Strickland, Maia Miguelez, et al.
CNS Spectrums|March 20, 2014
Efficacy of adjunctive aripiprazole in patients with major depressive disorder whose symptoms worsened with antidepressant monotherapyJ Craig Nelson, Zia Rahman, Kimberly K Laubmeier, et al.
Pageof 103

Showing results (751-760 of 1,025) with videos related to

Sort By:
Pageof 103
EJNMMI Research|July 3, 2026
[<sup>18</sup>F]MNI-1054, a novel PET ligand for lysine-specific histone demethylase 1 A (LSD1): first-in human validation and enzyme occupancy of the LSD1 inhibitor TAK-418Adam J Schwarz, Christine M Sandiego, Cristian Constantinescu, et al.
Animal Nutrition (Zhongguo Xu Mu Shou Yi Xue Hui)|October 27, 2021
Implications of excreta uric acid concentrations in broilers offered reduced-crude protein diets and dietary glycine requirements for uric acid synthesisPeter H Selle, David I Cantor, Leon R McQuade, et al.
Journal of Neurodevelopmental Disorders|August 10, 2019
Phenotypic characterization of individuals with SYNGAP1 pathogenic variants reveals a potential correlation between posterior dominant rhythm and developmental progressionAndres Jimenez-Gomez, Sizhe Niu, Fabiola Andujar-Perez, et al.
Neuropsychiatric Disease and Treatment|June 10, 2011
Long-term safety and tolerability of open-label aripiprazole augmentation of antidepressant therapy in major depressive disorderRobert M Berman, Michael E Thase, Madhukar H Trivedi, et al.
The International Journal of Neuropsychopharmacology|February 17, 2017
Aripiprazole Once-Monthly 400 mg: Comparison of Pharmacokinetics, Tolerability, and Safety of Deltoid Versus Gluteal AdministrationArash Raoufinia, Timothy Peters-Strickland, Anna-Greta Nylander, et al.
American Journal of Biological Anthropology|March 20, 2025
The Future of Forensic Anthropology Practice and Education: Competencies, Certification, and LicensureNatalie R Langley, MariaTeresa A Tersigni-Tarrant, Nicholas V Passalacqua, et al.
Plos Pathogens|February 15, 2013
Plasmodium falciparum malaria elicits inflammatory responses that dysregulate placental amino acid transportPhilippe Boeuf, Elizabeth H Aitken, Upeksha Chandrasiri, et al.
Journal of Psychopharmacology (Oxford, England)|December 17, 2009
Evaluation of akathisia in patients with schizophrenia, schizoaffective disorder, or bipolar I disorder: a post hoc analysis of pooled data from short- and long-term aripiprazole trialsJohn M Kane, Thomas R E Barnes, Christoph U Correll, et al.
Journal of Clinical Psychopharmacology|April 7, 2017
Aripiprazole Once-Monthly in the Treatment of Acute Psychotic Episodes in Schizophrenia: Post Hoc Analysis of Positive and Negative Syndrome Scale Marder Factor ScoresZahinoor Ismail, Timothy Peters-Strickland, Maia Miguelez, et al.
CNS Spectrums|March 20, 2014
Efficacy of adjunctive aripiprazole in patients with major depressive disorder whose symptoms worsened with antidepressant monotherapyJ Craig Nelson, Zia Rahman, Kimberly K Laubmeier, et al.
Pageof 103